CXCL10 and tropical spastic paraparesis: HAM/TSP patients with transcontinental subtype showed lower levels of HBZ mRNA expression (Yasuma et al. 2016a) and higher levels of CXCL10, which has been proposed to be a prognostic biomarker for HAM/TSP (Naito et al. 2018).